Alnylam Pharmaceuticals Inc (BSP:A1LN34)
R$ 63.06 +1.32 (+2.14%) Market Cap: 168.76 Bil Enterprise Value: 158.31 Bil PE Ratio: 46.49 PB Ratio: 24.71 GF Score: 66/100
Sorry the transcript is not found. Please try another one.